SCHEMBL30906353

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	4/20	0.59

▸	EP300	Q09472	1/20	0.56

▸	HIF1A	Q16665	1/20	0.56

▸	NTSR1	P30989	8/20	0.55

▸	NTSR2	O95665	6/20	0.55

▸	SORT1	Q99523	5/20	0.55

▸	F2	P00734	2/20	0.55

▸	NPY2R	P49146	4/20	0.54

▸	NPY4R	P50391	4/20	0.54

▸	NPY5R	Q15761	4/20	0.54

▸	NPY1R	P25929	3/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29856042	0.93	RAMP3 (0.56)	CALCREP300HIF1ANTSR1F2
SCHEMBL31000876	0.91	CALCR (0.61)	CALCREP300HIF1ANTSR1NTSR2
SCHEMBL30429242	0.90	CALCR (0.63)	CALCREP300HIF1AF2NPY2R
SCHEMBL31683307	0.89	NPY2R (0.62)	CALCRNTSR1NTSR2SORT1NPY2R
SCHEMBL30726587	0.89	RAMP3 (0.61)	CALCREP300HIF1ANTSR1F2
SCHEMBL30262137	0.89	NTSR1 (0.58)	CALCRNTSR1NTSR2SORT1F2
SCHEMBL31000918	0.89	RAMP3 (0.58)	CALCRNTSR1F2NPY2RNPY4R
SCHEMBL30304511	0.88	CALCR (0.69)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30831411	0.88	CALCR (0.63)	CALCRF2NPY2RNPY4RNPY5R
SCHEMBL30906513	0.88	RAMP3 (0.55)	CALCRNTSR1F2NPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed